Prior to cell collection, cells are transiently treated with Thiazovivin (Rock inhibitor, 6µg/ml; StemCell. Cat. N°. 72252) to increase cell viability. HiPSCs colonies are then enzymatically disrupted with Dispase (StemCell. Cat. N°. 07923), rinsed in cell culture medium and transferred to EB medium (50% of mTeSR™1 and 50% of hESs cell culture medium (78% KO DMEM ; 20% KSR 20% ; 1% Glutamax ; 1% non-essential amino acids ; 2.5 µL β-Mercaptoethanol) in the presence of Thiazovivin (6µg/ml). Cells are grown in suspension in untreated petri dishes. Embryoid bodies are maintained between 15 to 30 days with medium replacement every two days. Expression of pluripotency and differentiation markers is quantified at different time points (Day 5, 10, 15 or 30).
Supplementary table 1: List of primary fibroblasts and hiPSCS clones.
BAMS-Case 1; BAMS-Case 2 and BAMS-Case 9 were described in (12 Error bars represent SD from three independent reactions. The AG04 and AG08 control clones were previously described (13) . Expression was normalized to three housekeeping genes (GAPDH, HPRT and PPIA). Mean methylation level
